Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes COVID-19.
At the same time, the scaling up of the gold-standard RT-PCR tests and loosening the testing regimen has also significantly helped in diagnosing a large number of infections which would otherwise have gone untraced, the experts said.
In an advisory to states on setting up coordination committees for distribution of the Covid-19 vaccine, the health ministry has said introduction of the shots will span over a year with multiple groups being included sequentially, starting from health care workers, while also asking governments to be vigilant about disinformation on social media.
RTI activist Venkatesh Nayak had filed an application under RTI Act seeking information on the terms of reference of the National Expert Group of Vaccine Administration for Covid-19 chaired by NIti Aayog member (health) Dr V K Paul.
Depending on safety and other factors, the company plans to test in even younger children afterwards, said Sadoff, a vaccine research scientist at J&J's Janssen unit, without giving a timeline.
The Centre has asked states to constitute committees for coordination and overseeing COVID-19 vaccination drive while ensuring minimal disruptions in other routine healthcare services and stressed early tracking of social media to dispel rumours which could impact the community acceptance of coronavirus inoculation.
Ranked at number five among global pharma and biotech companies in 2020, the Bengaluru-headquartered biopharmaceuticals company said it has moved up from number seven in 2018 and number six in 2019.
The company said that by December, it expected to have produced enough drug to treat 2 million patients and that it was studying an inhaled form of the drug that could expand its use to outpatients.
While most studies so far have found that antibodies to the novel coronavirus go away quickly, this new study conducted at the Icahn School of Medicine at Mount Sinai in New York found the opposite.
While some experts have raised concerns about India’s capability to safely store and transport a potential vaccine, a Niti Aayog member said the nation’s health workers won’t need separate training to handle the inoculations, most of which can be stored at room temperature and will be distributed through already existing systems.
Chairman of Dr Reddys Laboratories, Satish Reddy said, "We are pleased with the collaboration with BIRAC as an advisory partner for clinical trials of the Sputnik V vaccine in India. We look forward to working with them to accelerate our efforts in bringing the vaccine to India."
Advocate M L Sharma petitioner in-person referred to the bench, also comprising Justices A S Bopanna and V Ramasubramanian, the World Health Organization (WHO) report of October 15 and said that nowhere these medicines are designated officially as medicines for coronavirus.
While the global figure for COVID-19 cases per million is 5,552, India is reporting 5,790 cases per million population.USA, Brazil, France, UK, Russia and South Africa are witnessing much higher numbers.
Biological E has got the technology transferred from US drug maker Johnson and Johnson (J&J). J&J has also given manufacturing rights of its SARS-Cov2 vaccine to Biological E, a move that could bring J&J’s vaccine to India by mid 2021.
